Le Lézard
Classified in: Health
Subjects: CCA, TDS, FVT

Boston Scientific to Participate in Evercore ISI and Piper Jaffray Healthcare Conferences


MARLBOROUGH, Mass., Nov. 21, 2019 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in two investor conferences this December.

Boston Scientific Corporation (PRNewsFoto/Boston Scientific Corporation) (PRNewsFoto/Boston Scientific Corporation)

On Wednesday, December 4, 2019, Susie Lisa, vice president, Investor Relations, and Lauren Tengler, director, Investor Relations, will participate in a 40-minute question-and-answer session with the host analyst at the Evercore ISI HealthCONx Conference in Boston, Massachusetts. The session will begin at approximately 11:00 a.m. EST.

On Thursday, December 5, 2019, Susie Lisa will participate in a 25-minute question-and-answer session with the host analyst at the Piper Jaffray Healthcare Conference in New York City. The session will begin at approximately 11:00 a.m. EST.

A live webcast and replay of the webcast for both events will be accessible at investors.bostonscientific.comhttp://www.bostonscientific.com/investors. The replay will be available beginning approximately one hour following the completion of each event.

About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for 40 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.

CONTACTS


Media:                                             

Investors:

Katie Schur                                               

Susie Lisa, CFA

508-683-5574 (office)                        

508-683-5565 (office)

Media Relations                                     

Investor Relations

Boston Scientific Corporation               

Boston Scientific Corporation

[email protected]                            

[email protected]

 

SOURCE Boston Scientific Corporation


These press releases may also interest you

at 23:03
The report titled "Anti-Adhesion Products Market by Product Type (Natural Adhesion Barriers, Synthetic Adhesion Barriers), Product Form (Film Formulation, Gel Formulation, Liquid Formulation), Application, End-User - Global Forecast 2024-2030" is now...

at 22:29
Product: Meat and vegetable products Issue: Food - Microbial Contamination - Listeria Distribution:British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

at 22:03
The report titled "Contract Research Organization Services Market by Type (Clinical Research Services, Consulting Services, Data Management Services), Trial Phase (Phase I, Phase II, Phase III), Therapeutic Area, Molecule Type, End-User - Global...

at 21:30
Greenbrook TMS Inc. ("Greenbrook" or the "Company") today announced its fiscal year ended December 31, 2023 ("Fiscal 2023") operational and financial results. All values in this news release are in United States dollars, unless otherwise stated....

at 20:25
AIDS Healthcare Foundation applauds the government of Colombia for issuing a compulsory license on HIV drug dolutegravir, which will allow the country to access affordable generic versions of the treatment as an alternative to the costly branded...

at 20:12
BCACC is pleased to announce that its Deputy Registrar, Kathy Lauriente, has been honoured with the Distinguished Service Award from Thompson Rivers University. The award recognizes stellar contributions to the University, community, and the public...



News published on and distributed by: